XML 82 R66.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders Equity - Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders (Details)
 12 Months Ended
Dec. 31, 2025
$ / shares
shares
Common Stock Issued to Stockholders [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Number of Shares of Common Stock Underlying Warrants 1,154,462
Common Stock Issued to Stockholders [Member] | 2021 Registered Direct Offering Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Jul. 28, 2021
Expiration Date Jan. 28, 2027
Exercise Price Per Share | $ / shares $ 950
Number of Shares of Common Stock Underlying Warrants 14,808
Common Stock Issued to Stockholders [Member] | Merger Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Mar. 15, 2024
Expiration Date Jan. 28, 2027
Exercise Price Per Share | $ / shares $ 950
Number of Shares of Common Stock Underlying Warrants 11,404
Common Stock Issued to Stockholders [Member] | Private Placement Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Mar. 15, 2024
Expiration Date Jul. 09, 2026
Exercise Price Per Share | $ / shares $ 43.91
Number of Shares of Common Stock Underlying Warrants 203,444
Common Stock Issued to Stockholders [Member] | Registered Pre-Funded Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Feb. 25, 2025
Expiration Date Apr. 21, 2030
Exercise Price Per Share | $ / shares $ 0.0019
Number of Shares of Common Stock Underlying Warrants 42,381
Common Stock Issued to Stockholders [Member] | Private Pre-Funded Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Feb. 25, 2025
Expiration Date Apr. 21, 2030
Exercise Price Per Share | $ / shares $ 0.0019
Number of Shares of Common Stock Underlying Warrants 46,232
Common Stock Issued to Stockholders [Member] | Common Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Feb. 25, 2025
Expiration Date Apr. 21, 2030
Exercise Price Per Share | $ / shares $ 17.68
Number of Shares of Common Stock Underlying Warrants 312,503
Common Stock Issued to Stockholders [Member] | Inducement Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Feb. 25, 2025
Expiration Date Apr. 21, 2030
Exercise Price Per Share | $ / shares $ 17.68
Number of Shares of Common Stock Underlying Warrants 366,087
Common Stock Issued to Stockholders [Member] | A&R Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Feb. 25, 2025
Expiration Date Apr. 21, 2030
Exercise Price Per Share | $ / shares $ 0.0019
Number of Shares of Common Stock Underlying Warrants 157,603
Common Stock [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Number of Shares of Common Stock Underlying Warrants 51,458
Common Stock [Member] | Private Warrants issued to scientific founders [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Nov. 27, 2017 [1]
Expiration Date [1]
Exercise Price Per Share | $ / shares [1]
Number of Shares of Common Stock Underlying Warrants 16 [1]
Common Stock [Member] | Landlord Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Mar. 15, 2024 [2]
Expiration Date Jan. 28, 2027 [2]
Exercise Price Per Share | $ / shares $ 950 [2]
Number of Shares of Common Stock Underlying Warrants 1,316 [2]
Common Stock [Member] | Agents Warrants [Member]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders [Line Items]  
Issuance Date Mar. 15, 2024
Expiration Date Jul. 09, 2026
Exercise Price Per Share | $ / shares $ 43.91
Number of Shares of Common Stock Underlying Warrants 50,126
[1] In November 2017, BiomX Israel issued 298 warrants to its founders. The warrants were fully vested at their grant date and will expire immediately prior to a consummation of an M&A transaction. The warrants did not expire as a result of the Recapitalization Transaction and have no exercise price. The Merger Agreement as described in note 1C does not apply for such M&A transaction as defined in the grant agreement.
[2] See Note 5